These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
473 related articles for article (PubMed ID: 10879242)
1. Comparison of alpha-fetoprotein with some other tumour markers in Malaysians with hepatocellular carcinoma. Lopez JB; Balasegaram M; Timor J; Thambyrajah V Malays J Pathol; 1997 Jun; 19(1):53-8. PubMed ID: 10879242 [TBL] [Abstract][Full Text] [Related]
2. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961 [TBL] [Abstract][Full Text] [Related]
3. Differential tumor markers and hepatitis markers profile in liver tumors. Khalifa A; Mady EA; Abadeer N; Kamal A Anticancer Res; 1999; 19(4A):2495-500. PubMed ID: 10470181 [TBL] [Abstract][Full Text] [Related]
4. [Application of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma]. Jia HL; Xing XJ; Ye QH; Qin LX Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):440-3. PubMed ID: 18795617 [TBL] [Abstract][Full Text] [Related]
5. Serum ferritin in hepatocellular carcinoma. Zhou XD; Stahlhut MW; Hann HL; London WT Hepatogastroenterology; 1988 Feb; 35(1):1-4. PubMed ID: 2452122 [TBL] [Abstract][Full Text] [Related]
6. Comparison of serum tumor markers for intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Tao LY; Cai L; He XD; Liu W; Qu Q Am Surg; 2010 Nov; 76(11):1210-3. PubMed ID: 21140686 [TBL] [Abstract][Full Text] [Related]
7. [Tumor markers--personal experience. The use of tumor markers for cancer of digestive organs]. Ishii M Gan To Kagaku Ryoho; 1991 May; 18(6):1059-65. PubMed ID: 1709347 [TBL] [Abstract][Full Text] [Related]
8. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy. Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841 [TBL] [Abstract][Full Text] [Related]
9. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452 [TBL] [Abstract][Full Text] [Related]
10. [Optimal cut-off value of PIVKA-II for diagnosis of hepatocellular carcinoma--using ROC curve]. Kim MJ; Bae KW; Seo PJ; Jeong IK; Kim JH; Lee BH; Bang KT; Kim DW; Song IH Korean J Hepatol; 2006 Sep; 12(3):404-11. PubMed ID: 16998292 [TBL] [Abstract][Full Text] [Related]
11. Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein <20 ng/mL. Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A; Kanke F; Satomura S Cancer Sci; 2011 May; 102(5):1025-31. PubMed ID: 21244578 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma. Cui R; Wang B; Ding H; Shen H; Li Y; Chen X Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656 [TBL] [Abstract][Full Text] [Related]
13. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma]. Sun GZ; Zhao XY; Li JH; Zhao GQ; Wang SX; Kong SL Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1986-8. PubMed ID: 19062741 [TBL] [Abstract][Full Text] [Related]
14. Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma. Okuda H; Nakanishi T; Takatsu K; Saito A; Hayashi N; Takasaki K; Takenami K; Yamamoto M; Nakano M Cancer; 2000 Feb; 88(3):544-9. PubMed ID: 10649245 [TBL] [Abstract][Full Text] [Related]
15. The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance. Huo TI; Hsia CY; Chu CJ; Huang YH; Lui WY; Wu JC; Lee PC; Chi CW; Lee SD J Surg Oncol; 2007 Jun; 95(8):645-51. PubMed ID: 17530668 [TBL] [Abstract][Full Text] [Related]
16. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma. Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443 [TBL] [Abstract][Full Text] [Related]
17. Combination of alpha-1-acid glycoprotein and alpha-fetoprotein as an improved diagnostic tool for hepatocellular carcinoma. Bachtiar I; Santoso JM; Atmanegara B; Gani RA; Hasan I; Lesmana LA; Sulaiman A; Gu J; Tai S Clin Chim Acta; 2009 Jan; 399(1-2):97-101. PubMed ID: 18926809 [TBL] [Abstract][Full Text] [Related]
18. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis. Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma. Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803 [TBL] [Abstract][Full Text] [Related]
20. A comparative study of four serological tumor markers for the detection of breast cancer. Clinton SR; Beason KL; Bryant S; Johnson JT; Jackson M; Wilson C; Holifield K; Vincent C; Hall M Biomed Sci Instrum; 2003; 39():408-14. PubMed ID: 12724928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]